Despite its availability in food, some individuals struggle to maintain sufficient B12 levels due to dietary restrictions, medical conditions, or absorption issues
Continuing for 1-2 weeks after visible wound closure supports the ongoing remodeling phase where collagen continues maturing
Cross-trial comparisons reveal broadly similar efficacy, with differences in weight reduction and glycemic regulation
Elevated dose: 3 mg of GHK-Cu + 600 mcg each of BPC-157, TB-4, KPV
It is used to treat and prevent niacin deficiency (pellagra), folate deficiency, and vitamin B12 deficiency
Peptic ulcer disease represents a logical target indication, with animal models demonstrating accelerated ulcer healing and reduced ulcer formation with both systemic and local BPC-157 administration